Medindia
Medindia LOGIN REGISTER
Advertisement

Legal Cannabis Market Projected to Grow

Wednesday, December 7, 2016 Drug News
Advertisement
NEW YORK, December 7, 2016 /PRNewswire/ --
Advertisement

http://www.Financialbuzz.com - After the elections, a total of 28 states have accepted medical marijuana laws along with the District of Columbia, and legal recreational marijuana laws in eight states. The legal cannabis industry in the U.S. is projected to total $49.7 billion between 2016 and 2020, with revenues in 2020 alone anticipated at $15.2 billion, reported data analytics of the cannabis market New Frontier and Arcview Market Research. GrowGeneration Corporation (OTC: GRWG), Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE), Terra Tech Corporation (OTC: TRTC), General Cannabis Corporation (OTC: CANN), Medicine Man Technologies Inc. (OTC: MDCL).
Advertisement

The state of California was one of the four states where the recreational use of cannabis was voted in favor for and is also the largest market for the legal cannabis industry, making up of 12 percent of Americans. New Frontier and Arcview Market Research, has released the 2016 California Legal Cannabis Market State Profile, disclosing the potential growth of the legal cannabis market in California. It's projected that over the next five years, the market in California alone will grow at a compounded annual rate of 18.5%, from $2.76 billion in 2015 to $6.5 billion by 2020.

GrowGeneration Corporation (OTCQB: GRWG) one of the largest specialty retail hydroponic and organic gardening store chains, selling to both the commercial and home cannabis markets, with currently 10 locations in Colorado and 1 location in California, announced recently, "that it has signed a 5-year lease on a 10,000 square foot facility in Las Vegas, Nevada for its 12th store. The Las Vegas location will serve as retail and warehouse location, and will service the growing number of both commercial and home growers in the Nevada market.

Nevada presents significant growth opportunities for GrowGen in the legal cannabis market. The potential is attributed to the state's rank as a top tourism desti-nation, generous patient reciprocity laws, and the allowance for medical cannabis businesses to be formed as for-profit enterprises. Recreational use sales are expected to begin in 2017, and grow quickly. According to New Frontier, the combined medical and recreational use sales in Nevada are expected to reach nearly $622 million by 2020. A major key to the industry's growth will be the demand from the state's strong tourism market, with an estimated 55 million visitors in 2016 alone."

"Commenting on GrowGen's expansion into Nevada, Darren Lampert, Co-Founder and CEO, said, "The passage of Nevada's recreational use legalization measure opens up the market for cultivation expansion like we have not seen before in the US. With this additional 10,000 sq. ft. of retail and warehouse space, conveniently located minutes from the Las Vegas strip, we believe we are to be the largest hydroponic store in the Nevada market. To best serve Nevada growers, we'll stock both commercial and home-grow sizes of all the equipment and growing supplies offered throughout the market today."  

"Executing and opening our GrowGen Nevada retail and warehouse operation furthers our business plan to aggressively expand our business. With the recent recreational legalization in Nevada, California, Massachusetts and Maine, and medical legalization in Florida, we consider those states as our key expansion markets. GrowGen is now operating at an annualized revenue run rate of over $9.0 million. We believe we're well positioned to continue to execute our expansion growth strategy, in order to offer a one-stop, personalized shopping solution for both the commercial and home grower alike."

Clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) reports positive results for its product pipeline, ZYN002 cannabidiol gel in phase 1 studies at 70th Annual Meeting of the American Epilepsy Society. The ZYN002 CBD gel was shown to be safe and well-tolerated across range of doses tested in healthy subjects and adult epilepsy patients with focal seizures and no impairment in cognitive performance or changes in psychological health were observed. The gel is formulated as a permeation-enhanced gel for transdermal delivery in development for the treatment of epilepsy, osteoarthritis and Fragile X syndrome.

Terra Tech Corporation (OTCQX: TRTC) engages in the design, marketing, and sale of hydroponic equipment with proprietary technology to create sustainable solutions for the cultivation of indoor agriculture. It operates through two segments, Hydroponic Produce and Cannabis Products. Terra Tech has multiple subsidiary businesses which include Blüm, IVXX Inc., and Edible Garden. Blüm's retail medical cannabis facilities focus on providing the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces medical cannabis-extracted products for regulated medical cannabis dispensaries throughout California. The Company's wholly-owned subsidiary, Edible Garden utilizes time-tested, classic Dutch hydroponic farming methods to grow herbs and leafy greens in a safe and healthy environment.

General Cannabis Corp. (OTCQB: CANN) provides services to the regulated cannabis industry in the United States that includes the leasing of cultivation space and related facilities to licensed marijuana growers and dispensary owners along with the provision of security service. The company does this through a combination of operating divisions such as real estate, consulting, security, financing and the distribution of vital infrastructure products to cultivate facilities and dispensaries. As a holding company, its subsidiaries are able to leverage the strengths of each other to help improve its company.

Medicine Man Technologies Inc. (OTCQB: MDCL) offers services in consulting, cultivation, and dispensary operations. Through its pre-licensure consulting services, they support other marijuana companies in a competitive or non-competitive state application process with the goal of helping their team secure a state-issued operating license. Its cultivation technology offers risk-averse cannabis cultivation technology that delivers consistent, high quality, high yield production within a clean-room style environment and the company's state-of-the-art dispensary model ensures patients and consumers safe and secure access to a variety of medical/recreational cannabis products.

Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"  

Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. Financialbuzz.com expects to be compensated five thousand dollars for financial news dissemination and pr services by growgeneration corp. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit: http://www.financialbuzz.com

For further information:  Media Contact: [email protected], +1-877-601-1879 

 

SOURCE FinancialBuzz.com

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close